Table 2.
Receptor | agonist | reference | antagonist | reference |
---|---|---|---|---|
DP1 | BW245C | Rangachari et al. 1995 | BWA868C | Rangachari et al. 1995 |
TS-022 | Arai et al. 2007 | MK-0524 | Chang et al. 2007 | |
- | - | S-5751 | Arimura et al. 2001 | |
DP2 | Indomethacin | Hirai et al. 2002 | Ramatroban | Sugimoto et al. 2003 |
L-888,607 | Gervais et al. 2005 | - | - | |
EP1 | ONO-DI-004 | Sugimoto and Narumiya 2007 | ONO-8713 | Sugimoto and Narumiya 2007 |
17-phenyl trinor PGE2 | Dey et al. 2006 | - | - | |
EP2 | ONO-AE1-259 | Sugimoto and Narumiya 2007 | PF-04418948 | af Forselles et al. 2011 |
butaprost | Kashmiry et al. 2018 | - | - | |
EP3 | ONO-AE-248 | Norel et al. 2004 | enprostil | Abramovitz et al. 2000 |
SC-46275 | Savage et al. 1993 | M&B 28767 | Abramovitz et al. 2000 | |
MB28767 | Kotani et ai. 2000 | - | - | |
Sulprostone | Jin et al. 1997, Abramovitz et al. 2000 | - | - | |
EP4 | ONO-AE1-329 | Sugimoto and Narumiya 2007 | ONO-AE3-208 | Sugimoto and Narumiya 2007 |
tetrazolo PGE1 | Jones et al. 2009 | CJ-042794 | Jones et al. 2009 | |
IP | Cicaprost | Jones et al. 2009 | RO-1138452 | Jones et al. 2009 |
Carbacyclin | Jones et al. 2009 | RO-3244794 | Jones et al. 2009 | |
iloprost | Jones et al. 2009 | - | - | |
19(S)-HETE | Tunaru et al. 2016 | - | - | |
TP | U-46619 | Abramovitz et al. 2000 | AH-23848 | Jones et al. 2009 |
STA2 | Hirata et al. 1996 | Ramatroban | Jones et al. 2009 | |
I-BOP | Hirata et al. 1996 | Vapiprost | Jones et al. 2009 | |
- | - | SQ29548 | Wright et al. 1998 | |
- | - | S-145 | Ushikubi et al. 1989b | |
FP | Fluprostenol | Sharif et al. 2000b | OBE022 | Pohl et al. 2018 |
Cloprostenol | Anderson et al. 1999 | THG113 | Peri et al. 2002 | |
Latanoptost | Abramovitz et al. 2000 | AS604872 | Jones et al. 2009 |